Behçet's disease
ICD-10 M35.2 · ICD-11 4A62

Treatment of Behçet's Disease in Behçet's Syndrome with Arthritis

Arthritis is a recognised manifestation of Behçet's syndrome and defines a specific clinical sub-population requiring a focused therapeutic approach. This page summarises the key considerations for this scenario.

Clinical Scenario

This protocol applies to patients with Behçet's syndrome in whom arthritis is the presenting or predominant feature. Joint involvement — whether isolated to a single joint or more widespread — directly informs the selection and sequencing of treatment.

Treatment Approach — Partial Overview

Management in this setting begins with an established oral agent recommended as initial therapy for arthritis in Behçet's syndrome. For acute disease confined to a single joint, a targeted local intervention is also an option.

The complete regimen — specific agents, sequencing, and clinical decision points — is available in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/annrheumdis-2018-213225

Colchicine should be the initial treatment in BS patients with acute arthritis.

Acute monoarticular disease can be treated with intra-articular glucocorticoids.

View source ↗